Police Dog Sniffs Out $10 Million Worth of Marijuana in One Night

You know what they say—a dog is a man’s best friend, unless it’s a police dog that just sniffed out $10 Million worth of his marijuana.

Ok, that might not be exactly how the catchphrase goes, but it does pertain to at least one Chicago man who attempted to traffic that amount of marijuana cross-country until he crossed paths with Jayda, a dog with quite the impressive schnoz.

Police Dog Sniffs Out $10 Million Worth of Marijuana in One Night

So much for police dogs being trained to ignore the smell of marijuana. Although, it’s pretty hard to ignore the smell of $10 million worth of the stuff.

On Thursday, Jayda helped Chicago PD confirm their suspicions that a driver from Midlothian, Texas was trafficking drugs from California. According to CBS Chicago, the stop and search was part of a long-standing organized crime investigation.

After a quick sniff job, Jayda uncovered over 1,500 lbs of cannabis in the vehicle and attached trailer, as well as a variety of pot products and paraphernalia. The vehicle had just touched down in Chicago before police conducted the search.

The man behind the wheel was 42-year-old Jason Tanner of Lakehead, California. According to the local news site, he was charged with possession of more than 5,000 grams of marijuana. The pot had a street value of approximately $10 million.

As of Tuesday Morning, the Chicago PD’s Facebook post has gone viral. As it stands, the post has received over 8,000 shares and counting.

The department’s Facebook post read:

“Chicago Police Officers assigned to the Narcotics Unit conducted a narcotics investigation which led to a traffic stop of a vehicle suspected in narcotics trafficking. A Police canine alerted to the scent of narcotics and a subsequent search of the vehicle resulted in over 1500 pounds of cannabis products with a street value of over $10,000,000 being recovered.

Officers learned that the narcotics were en route to Chicago from California. The driver of the vehicle was placed in custody and charged with Cannabis – Possess more than 5000 grams.

Thank you to Officers for your hard work in this large narcotics seizure.”

On Friday, Tanner’s bail was set at $50,000 for the incident. After being held at Cook County Jail on Monday, Tanner is due back in court on July 10.

Chicago Police are currently working alongside Drug Enforcement Administration agents in California to further investigate the ongoing case.

However, it’s unclear if Jayda still has her “paws” on this case.

Marijuana News: FDA Approves First-Ever Cannabis-Based Drug

The good marijuana news for GWPH is that the organization is giving its approval to Epidiolex. This is a type of oral solution for the treatment of seizures. This includes seizures from two types of rare epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.

This bit of marijuana news marks the first time in the history of the U.S. that the FDA has given its approval to a purified drug derived from marijuana. However, customers with concerns about psychoactive effects from the drug need not worry.

Epidiolex won’t be causing psychoactive effects comparable to marijuana. That’s because it doesn’t contain tetrahydrocannabinol (THC). THC is the active ingredient in marijuana that causes the “high” that users experience. Instead, patients are taking cannabidiol (CBD), which is another component of the drug.

The FDA notes that the current Controlled Substances Act requires Epidiolex be listed as a Schedule I substance due to its connection to marijuana. However, it has looked over the abuse potential of the drug and is advising the Drug Enforcement Administration on how to handle the situation.

The effects of Epidiolex could very well be a boon to patients with the two forms of epilepsy mentioned above. The drug went through three randomized, double-blind, placebo-controlled clinical trials to determine its effectiveness in treating the two diseases. It was shown to be more effective at reducing seizures, when taken with other drugs, than a placebo during these studies.

Despite all this good marijuana news, there are still some negative side effects to Epidiolex. These side effects are “sleepiness, sedation and lethargy; elevated liver enzymes; decreased appetite; diarrhea; rash; fatigue, malaise and weakness; insomnia, sleep disorder and poor quality sleep; and infections.”

Texas Republicans Come Out in Support of Marijuana Decriminalization

Texas Republicans have come out in support of marijuana decriminalization in their official party platform. State GOP delegates also approved an expansion of medical marijuana access and support for industrial hemp at their convention.

Nearly 10,000 delegates attended the state Republican Party convention last week. Before Saturday’s vote on the platform, delegates had the opportunity to learn about cannabis policy and regulation. In a first for the convention, three pro-pot groups and one anti-pot group had booths in the exposition area.

The platform approved by delegates contained more than 330 planks covering policy issues ranging from gay rights to immigration. Of those, four are related to the regulation of cannabis.

One plank calls for a change in state law to remove criminal penalties for cannabis possession. Instead, civil penalties would apply to adults caught with an ounce or less.

“We support a change in the law to make it a civil, and not a criminal, offense for legal adults only to possess one ounce or less of marijuana for personal use, punishable by a fine of up to $100, but without jail time,” .

Currently, adults possessing up to two ounces of pot can receive a six-month jail term and a fine of $2,000.

Another platform item seeks a federal rescheduling of marijuana under the Controlled Substances Act. “Congress should remove cannabis from the list of Schedule 1 and move to Schedule 2,” according to the document.

Republicans also support an expansion of the state medical marijuana program with a call for “the Texas Legislature to improve the 2015 Compassionate Use Act to allow doctors to determine the appropriate use of cannabis to certified patients.”

Additionally, GOP delegates voted to “recognize industrial hemp as a valuable agricultural commodity.” They also urged “the Texas Legislature to pass legislation allowing cultivation, manufacture, and sale of industrial hemp and hemp products.”

Cannabis Activists React to GOP Platform

Cannabis activists applauded the party’s stance on cannabis issues. Heather Fazio of Texans for Responsible Marijuana Policy told Forbes that the proposals would be positive changes for the state.

“Texas Republicans, like the majority of Americans, are ready to see more sensible marijuana policies enacted,” said Fazio. “Our state wastes valuable criminal justice resources arresting between 60,000-70,000 Texans annually. Delegates took a stand this week for a better approach. While it would be preferable for cannabis to be de-scheduled entirely, this call by the Texas GOP signifies a very positive shift in opinion. Outright prohibition is not working and Texas Republicans want to see Congress take action to make cannabis more accessible.”

Fazio also said that more Texans would be able to access medicinal cannabis if the GOP proposals become law.

“Under the current [medical cannabis] program, most patients are being left behind,” she said. “Texas conservatives are seeing the value of medical cannabis and want to see more inclusive access. Now we will take this to the Legislature for action during the 2019 legislative session.”

Under current law, only patients with intractable epilepsy may use low-THC cannabis oil after receiving approval from two doctors. The new platform calls for doctors, not lawmakers, to decide which patients might benefit from medical marijuana.

What You Need to Know About Canada’s Cannabis Act

Yesterday was a historic day for Canadians, as the Cannabis Act passed through the Senate after two years of intense debate. The landmark decision makes Canada the first G-7 country to legalize cannabis recreationally, with the first legal stores expected to open by September.

The bill passed on a vote 52 to 29, with several opposing Senators cited concerns that legalization for non-medical cannabis violated the UN drug control treaties.  Yet despite heated opposition, Bill C-45 is now making its way into law and is expected to come into effect 8-12 weeks after Royal Assent which is expected by the week’s end.

Independent Senator Tony Dean who sponsored the bill was elated celebrating the end of cannabis prohibition in Canada, “We have seen in the Senate tonight a historic vote that ends 90 years of prohibition of cannabis in this country, 90 years of needless criminalization, 90 years of a just-say-no approach to drugs that hasn’t worked.” Dean emphasized, “I’m proud of Canada today. This is progressive social policy.”

Amendments that were originally proposed by the Senate were struck down by the House of Commons, could have been disastrous for the industry. Originally, the Senate had proposed a ban on all cannabis swag, including t-shirts and tote bags and attempted to reinforce the province’s ability to ban homegrown cannabis.  Under the Cannabis Act, every Canadian can grow up to 4 plants which certain Senators complained would increase children’s access to cannabis. Senators ironically also attempted to decriminalize adults giving their children cannabis as young as age 16.

The Senate has also originally proposed disclosure of foreign investment, as millions of dollars poured into float Canadian cannabis companies from offshore tax havens like the Cayman Islands. These amendments were struck down by the House of Commons and did not make it to the final version of the bill, which led to a suspenseful voting session at the Senate after the stock markets closed for the day.

An Economic Boon

Not passing the bill would have been disastrous for Canadian economy, but now Canadian cannabis stocks expected to soar as soon as the markets open leading up into legalization. Shortly after the bill passed, Canada’s Prime Minister Justin Trudeau tweeted #PromiseKept, “It’s been too easy for our kids to get marijuana – and for criminals to reap the profits. Today, we change that.”

As trade wars between Canada and the US amp up, legalizing cannabis federally means that Canadian licensed producers can import and export for medical and scientific purposes, while US companies remained landlocked in legal states by federal prohibition.

Legalization for medical use occured in 2001 in Canada, with private companies expanding into cannabis starting in 2014 and growing into a robust industry now with over 100 licensed producers in 2018. Canada now boasts cannabis stocks as some of the highest traded, which are beginning to premier on the NASDAQ in 2018, while US cannabis penny stocks continue to fluctuate due to federal prohibition. It’s worth noting a lot of US cannabis brands have moved north with hopes of trading on the major exchanges, including MedMen, Dosist and Province Brands, with other companies licensing IP to Canadian companies including Dixie, Bhang, Greenhouse, O.PenVAPE, and many more.

While the first year of legalization in Canada products will be limited to dried flower and oil, Deepak Anand, Vice President of Government Relations at Cannabis Compliance Inc. was optimistic about diverse cannabis products being approved within a year of Royal Assent. “Health Canada has already started thinking about regulations surrounding forms of Cannabis not going to be legal on proclamation day.” On the retail side, he noted, “Provinces such as New Brunswick appeared far better prepared for a September legalization date when compared with BC or Ontario.”

While the west side of the country amps up for private retail, east of Ontario is primarily government retail outlets with potential for privatization as government swings right. Originally legalization was supposed to take place by July 1st on Canada Day but now is expected in September giving provinces more time for the rollout.

Justice, Freedom, and Cannabis

Despite the celebrations, many activists worry that legalization will ultimately leave out those who have most been affected by the war on drugs in Canada.  For those Canadians who have a criminal record for cannabis, there are no pardons proposed currently in the Cannabis Act. Having a criminal record or being suspected of breaking the law are grounds to deny someone a cannabis business license. Critics say that cannabis should take an equity perspective, especially with Canada’s massive diversity problem when it comes to cannabis. Health Canada is listening to criticism and recently announced that Indigenous cannabis applicants are being fast-tracked now to make up for the lack of diversity.

The new Cannabis Act includes micro-cultivation and micro-processors, which will be able to produce edibles, extracts and beverages by 2019. While marketing remains restrictive in Canada, there is the potential for farm gate sales for micros in the future as legalization potentially opening the door to licensed cannabis lounges, restaurants and cafes depending on provincial restrictions.

As for next steps for Canada, Trina Fraser co-managing partner and CannaLaw® group leader at Brazeau Seller Law is optimistic for the future of craft cannabis, “Hopefully the regulations will include implementation of previous proposals by the federal government, including ‘micro’ licences with lower regulatory burdens, clarity on security clearance requirements for prior illicit market participants and improved access for medical patients.”

It’s hard to know if legalization will truly be inclusive after almost a century of prohibition, whatever Canada does will set an example for the world. As the World Health Organization releases its pre-review for cannabis, according to Senior Policy Analyst for Transform Drug Policy Foundation and consultant for Health Canada’s legalization task force Steve Rolles, “This will have major repercussions at the UN.”

Rolles reflected that while the UN ignored Uruguay, and turned a blind eye to the US states, Canada is a major voice in the United Nations, so this will inevitably force the debate on drug policy reform back to center stage. “The malfunctioning and antiquated UN system is long overdue for some modernisation, so it comes a good moment. We hope the Canadian government can now show the same leadership at the UN they have shown domestically.”

New York to Offer Medical Marijuana as Prescribed Opioid Alternative

New York is set to significantly expand access to its medical cannabis program. Building off a change that added chronic pain to the list of qualifying conditions in 2016, the Department of Health will now allow anyone with a prescription for opioids to use medical marijuana as an alternative. Officials expect the new regulation will help grow a program struggling with access issues. They also hope to get more patients off of prescription opioids.

If You Have an Opioid Prescription, You Now Qualify to Use Medical Cannabis in New York

Opioid deaths are skyrocketing in New York, which legalized medical cannabis in 2014. One investigation found a 135 percent rise in deaths between 2013 and 2016.

In 2016, the opioid death rate was 15.1 per 100,000 people, nearly two percent higher than the national rate. And in an effort to combat the rapid rise of opioid overdoses and deaths across the state, the New York Health Department is making a major change to its medical marijuana program.

Health Department officials hope the change will help reduce the use of prescription opioids. On Monday, State Health Commissioner Howard Zucker announced that anyone with an opioid prescription would be eligible to use marijuana as an alternative medicine.

“So that means if an individual is taking prescription opioids, they could take medical marijuana as part of the program that were are pushing forward to hopefully come off prescription opioids as well,” Zucker told reporters.

Studies have found that medical cannabis can effectively treat chronic pain, without the dangerous side effects and addiction opioids cause. Other studies suggest cannabis can act as a “reverse gateway drug,” helping people struggling with addiction wean themselves off drugs.

The Health Department hopes that allowing doctors to prescribe cannabis instead of opioids will reduce the number of patients who end up addicted to drugs like OxyContin, Vicodin and Fentanyl.

Offering Medical Cannabis as an Opioid Alternative Could Help Lift New York’s Struggling MMJ Program

Gov. Andrew Cuomo signed the Compassionate Care Act into law in 2014. Since then, New York has struggled to grow its medical cannabis program. A short list of qualifying conditions, and restrictions on the kinds of cannabis products patients could access, hurt participation.

In 2016, New York added chronic pain to the list of qualifying conditions. The Health Department also made it possible for nurse practitioner and physicians assistants to make a medical cannabis recommendation.

Now, New York has 1,688 licensed caregivers and roughly 59,000 registered patients. Yet the program has licensed less than two dozen dispensaries across the state. The program has grown, but not as rapidly as advocates and patients would like.

Zucker feels allowing those with opioid prescriptions to use medical marijuana “is another way to move the program forward."

30 Arrested at Washington DC Marijuana Pop-Up Event

Marijuana pop-up events have been growing in popularity in Washington DC over the past month. That momentum has come to a grinding halt as DC cops crack down on the events. Over the weekend, 30 people were arrested at a marijuana pop-up.

Weekend Arrests

Over the weekend, police officers broke up what was described as a “marijuana pop-up event.” According to local news source WTOP, cops arrived to carry out a search warrant. It’s unclear what, exactly, the warrant was for.

Police quickly moved to break up the event. They seized multiple pounds of weed and other cannabis products containing THC. Additionally, they took around $10,000 in cash. Police also reportedly found three firearms.

Police arrested 30 people in connection with the pop-up. Reports said there were around 28 vendors at the event. It’s still unclear how many people were participating as sellers, vendors, or attendees.

DC’s Thriving Pop-Up Scene

Marijuana pop-ups have become pretty popular in the nation’s capital. The pop-ups have typically functioned without being harassed by law enforcement, thanks to a legal loophole.

In the fall of 2014, DC residents voted to legalize cannabis. The new law went into effect in February 2015. Under the new law, it’s legal for adults 21 and over to possess up to two ounces of cannabis. Adults can also smoke weed in private, but public consumption is not allowed.

Additionally, it’s legal for people 21 and older to give up to one ounce of weed to another adult. Adult DC residents are also allowed to grow up to six marijuana plants at home.

Although these laws technically don’t let people sell weed, the marijuana pop-up events function by “gifting” weed rather than selling it.

Vendors will sell non-marijuana products—like stickers, shirts, hats, or juice—and throw in some flower on the side, as a gift.

Since they are technically only selling the non-weed product, and giving the weed away to customers, vendors say they’re not actually violating any laws.

The Popularity of Pot Pop-Ups

Marijuana pop-ups have become so popular that DC locals tell High Timesthey’ve become an almost daily event.

Cannabis vendors who “gift” marijuana at pop-ups have established a working network of events and clients. In fact, residents in DC can easily find cannabis pop-ups being advertised on social media, especially Instagram.

Beyond the pop-ups, people have tried other methods for taking advantage of DC’s ambiguous weed laws. For example, some vendors offer home delivery. Of course, the product they’re actually selling is something like artwork, juice, or clothing. And after making a purchase, customers receive a little green on the side as a thank-you gift.

CEO of US marijuana company MedMen says Oregon, Colorado are 'horrible markets' to be in

• CNBC's Jim Cramer sits down with Adam Bierman, the co-founder and CEO of the marijuana dispensary operator whose stores have been dubbed the "Apple Stores of weed."
• Bierman explains why Oregon, Washington and Colorado are not considered ideal markets for weed retail.

Marijuana dispensary operator MedMen sees major hurdles in operating in Oregon, Washington and Colorado, where pot is medically and recreationally legal, co-founder and CEO Adam Bierman told CNBC on Monday.

Bierman, whose company functions in California, Nevada, New York and Florida, called the first three fully legal U.S. weed markets "horrible markets to be in" in an interview with "Mad Money" host Jim Cramer.

"[It's] good for business that those are tiny markets that, in the grand scheme of things, maybe matter not that much," the CEO said.

"What's really important to understand is every market since those markets came online [has] been supply constrained, so limited licenses and, most importantly, especially for the MedMen's case, the most arduous retail zoning restrictions known to man," Bierman continued.

While MedMen is licensed to operate in the United States, where some of its retail locations have been affectionately dubbed the "Apple Store of weed," the company is publicly traded in Canada on the Canadian Securities Exchange and the OTCQB Venture Market.

In early June, the Canadian Senate voted to legalize recreational marijuana nationwide. The move would make Canada the first and only country in the G-7 to fully legalize marijuana.

But Bierman won't stop at Canada.

"From the beginning, we've been the 'Why not?' people," he told Cramer. "Why can't you build a billion-dollar business in this industry? Why not? Why can't you take the biggest U.S. weed company and make it public and available for people to own all over the world? Now, there's a lot of roadblocks in that kind of an attitude and we can't list here in the U.S., so we have to list in Canada and, unfortunately, that's the only place to go. Now, fortunately, it is a place to go and they've been great partners."

According to MedMen, some of the company's California stores bring in over $20 million a year in revenue. When the company reaches $1 billion in revenues, Bierman said he'll "look at what's next."

Buffett's investing basics. Warren Buffett outlines the main investment principles he practices.

Learn More

Part of MedMen's mission is to make marijuana mainstream, as illustrated by its latest marketing campaign, "Forget Stoner." The visual ads attempt to buck the "stoner" stereotype with photos of professionals and others who say they use marijuana.

It could even help stem the opioid epidemic sweeping the United States by offering individuals an alternative solution to prescription pills, Bierman said.

"The concept of a stoner or a stoner image is something that's yesteryear," the CEO said. "This is about Chardonnay moms. This is about working dads. This is about marijuana substituting and replacing, you know, other things that people are already utilizing that, in some instances, are detrimental to their health."

France Opens First Coffee Shops Selling CBD Products

Among European Union nations, France has some of the toughest laws against cannabis. Yet the country of nearly 67 million people has one of the highest rates of cannabis consumption in Europe. Recognizing the demand, some French companies have figured out a way to satisfy customers’ desire for cannabis, in a way that doesn’t break the law.

Across France, “coffee shops” selling cannabis and hemp products are springing up. But customers won’t find any products with THC in them. Instead, these coffee shops are exclusively selling CBD products.

Paris Is The Latest City To Open CBD Coffee Shops

Tucked away in Paris’ chic 11th arrondissement, curious shoppers are lining up outside CofyShop, a cannabis store selling CBD products.

Everything on the shelves, from tinctures and syrups to vape juice, edibles, topicals and even herbs, contains a negligible amount of THC. Tetrahydrocannabinol (THC) is the cannabinoid that produces the euphoric sensations users commonly call a high.

But shoppers won’t find anything containing more than 0.2 percent THC in CofyShop. What they will find is a wide assortment of CBD products, mostly produced from hemp.

Still, the fact that France’s cannabis coffee shops aren’t selling anything that would get users high seems to be lost on some first-time customers.

“I want to find out if the stuff they’re selling gets you stoned,” Marc, a 21-year-old lined up outside the shop told the Telegraph. “In theory, it has less than 0.2 percent THC, but I’ve heard it contains more CBD and that should have an effect, at least to make you feel relaxed.”

Cannabidiol, or CBD, is one of the key therapeutic compounds in cannabis. The wide range of medicinal applications of CBD include its relaxing, anti-anxiety effects.

Researchers around the world are investigating how CBD can treat neurological diseases, reduce seizures, fight cancer and reduce inflammation. Their findings continue to corroborate anecdotal evidence about CBD’s effectiveness as a remedy for a number of ailments.

The availability of CBD products throughout France comes from a loosening of some cannabis laws. A growing awareness of the legality of CBD has also contributed to the coffee shop phenomenon.

French Health Minister Says CBD Products Are Legal

In May 2017, newly elected French President Emmanuel Macron appointed Agnès Buzyn to Minister of Solidarity and Health. And in November of that year, Buzyn made a statement regarding the legality of cannabis and hemp-derived CBD products.

Buzyn supports the use of medical cannabis and has re-opened debate about how to expand access to it. France legalized cannabis for medical use in 2013, but the program’s restrictions make it a non-starter for most patients.

But in November, Buzyn announced that CBD was legal for public consumption under two conditions. First, products had to adhere to the 0.2 percent THC limit. And second, producers and retailers had to refrain from making any health claims about the products.

French authorities are also keeping a close eye on the activity of these shops, to make sure no illegal products end up on their shelves.

CBD products are undeniably increasing in popularity across France, drawing criticism from some and support from others. For the most part, however, the public seems to think CBD products are simply “low strength” versions of cannabis containing THC.

Critics are deploying gateway theory to suggest legal CBD will lead people to consuming illicit THC products. Supporters are excited to have access to high quality, potentially therapeutic products.

French cannabis coffee shops import all their CBD products from neighboring Switzerland. On average, shops are selling CBD for about US$15 per gram.

Donald Trump Teases Support for Bipartisan Medical Marijuana Bill

Just one day after Sens. Cory Gardner and Elizabeth Warren formally announced a bi-partisan bill to protect states’ rights to legalize cannabis, President Donald Trump hinted he might support the legislation if it can clear Congress. The President’s comment is, in fact, the third he has made in reference to Colorado Sen. Cory Gardner’s idea for a “states’ rights” approach to marijuana legalization. And now that the legislation is officially in the pipeline, Trump’s latest remarks suggest he hasn’t withdrawn his support.

Sen. Gardner Is Keeping Pressure On Trump To Support A States’ Rights Approach To Cannabis Legalization

Colorado Sen. Cory Gardner opposed his state’s efforts to legalize adult-use cannabis. But in a recent interview with NBC’s Morning Joe, Sen. Gardner acknowledged that “there’s no going back” on the issue of legalization.

Recognizing Coloradans’ desire for a legal and regulated cannabis program, Gardner teamed up with Massachusetts Sen. Elizabeth Warren to launch the STATES Act.

The Strengthening the Tenth Amendment Through Entrusting States Act would both protect states’ legal cannabis operations from federal prosecution and make essential services like banking and insurance available to the industry.

Sen. Gardner sees marijuana legalization as an opportunity to create a strongly federalist policy that lets states chart their own course on the issue. And framing legalization as fundamentally about states’ rights has also appealed to President Trump, Gardner said.

April was the first occasion Gardner was able to coerce support for his idea from the Trump administration. After Trump’s Attorney General Jeff Sessionsannounced a federal policy reversal on marijuana that threatened states’ legal medical and adult-use cannabis programs, Gardner held up confirmations for Sessions’ Justice Department nominees.

Sen. Gardner only ended his standoff with the Justice Department after Trump gave assurances his administration would not go after Colorado’s legal cannabis businesses. Furthermore, Gardner said Trump told him he would support a legislative solution with a states’ rights approach, the Washington Post reported.

Sen. Gardner also checked in with Trump on Wednesday, before he and Sen. Warren formally announced the STATES Act. Gardner reminded Trump about his previous comments and told the President about the aims of the new legislation. “He liked the idea—the concept,” Gardner said.

Will Donald Trump Support the Bill?

In a 20-minute exchange with reporters at the White House, the press pool asked President Trump about the Warner-Gardner legislation. “I probably will end up supporting it,” Trump told reporters, according to The Denver Post.

Gardner and Warren were pleased by Trump’s comment on the STATES Act. They hope the President’s remarks and the bill’s bi-partisan support will give it a boost in the Senate.

Legislators in the lower chamber are also supporting the Warner-Gardner bill. Reps. Earl Blumenauer (D-Oreg.) and David Joyce (R-Ohio) are sponsoring a bipartisan companion bill in the House. But their bill would amend the Controlled Substances Act to prevent the federal government from prosecuting individuals or entities that comply with state, U.S. territory, D.C. and tribal cannabis law.

Marijuana businesses threaten to leave Colorado after governor's vetoes

Marijuana industry and patient advocates joined state legislators at a news conference Thursday to condemn Gov. John Hickenlooper for vetoing three marijuana-related bills in the past week in a state that saw $1.5 billion in medical and retail marijuana sales in 2017, according to the Colorado Department of Revenue.

Bruce Nassau, board chairman of the Marijuana Industry Group, said the veto of House Bill 1011 is especially troubling for the industry.

“I have spoken with, I would say, three or four different organizations, a couple of whom have indicated a consideration to leave the state because of the now lack of availability of public capital,” Nassau said.